FDA Issues Final Guidance on PBPK Analyses

The FDA released final guidance for drug sponsors on the content and formatting of physiologically-based pharmacokinetic (PBPK) analyses, including an expanded section on formatting and a simplified section on software.
Source: International Pharmaceutical Regulatory Monitor